Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003439
Status:
COMPLETED
Last Update Posted:
2013-02-07
First Post:
1999-11-01
Brief Title:
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cancer |
Keywords:
| Name | View |
|---|---|
| stage IV colon cancer | View |
| stage IV gastric cancer | View |
| recurrent gastric cancer | View |
| recurrent pancreatic cancer | View |
| stage IV rectal cancer | View |
| recurrent colon cancer | View |
| recurrent rectal cancer | View |
| stage IV anal cancer | View |
| recurrent anal cancer | View |
| stage IV ovarian epithelial cancer | View |
| recurrent ovarian epithelial cancer | View |
| metastatic gastrointestinal carcinoid tumor | View |
| recurrent gastrointestinal carcinoid tumor | View |
| advanced adult primary liver cancer | View |
| recurrent adult primary liver cancer | View |
| stage IV endometrial carcinoma | View |
| recurrent endometrial carcinoma | View |
| small intestine adenocarcinoma | View |
| unresectable gallbladder cancer | View |
| recurrent gallbladder cancer | View |
| unresectable extrahepatic bile duct cancer | View |
| recurrent extrahepatic bile duct cancer | View |
| recurrent small intestine cancer | View |
| stage IV prostate cancer | View |
| recurrent prostate cancer | View |
| fallopian tube cancer | View |
| primary peritoneal cavity cancer | View |
| stage IV pancreatic cancer | View |